Kenneth P. Klinker, Levita K. Hidayat, Eric Wenzler, Joan-Miquel, Mary Motyl, C. Andrew DeRyke, & Karri A. Bauer. (2022). Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. MDPI AG.
Chicago Style (17th ed.) CitationKenneth P. Klinker, Levita K. Hidayat, Eric Wenzler, Joan-Miquel, Mary Motyl, C. Andrew DeRyke, and Karri A. Bauer. Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. MDPI AG, 2022.
MLA (9th ed.) CitationKenneth P. Klinker, et al. Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. MDPI AG, 2022.